GYRE(GYRE)
GYRE
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $102M | $131M | $434M | $262M | $307M |
| Low | $101M | $122M | $403M | $244M | $285M |
| High | $104M | $140M | $464M | $281M | $328M |
| EBITDA Avg | $-8M | $-11M | $-35M | $-21M | $-25M |
| Low | $-8M | $-11M | $-37M | $-23M | $-27M |
| High | $-8M | $-10M | $-33M | $-20M | $-23M |
| EBIT Avg | $-9M | $-12M | $-40M | $-24M | $-28M |
| Low | $-10M | $-13M | $-43M | $-26M | $-30M |
| High | $-9M | $-11M | $-37M | $-23M | $-26M |
| Net Income Avg | $-30M | $-10M | $207M | $27M | $35M |
| Low | $-33M | $-11M | $177M | $24M | $32M |
| High | $-27M | $-9M | $213M | $29M | $38M |
| EPS Avg | $-0.29 | $-0.10 | $1.89 | $0.26 | $0.34 |
| Low | $-0.32 | $-0.11 | $1.72 | $0.24 | $0.31 |
| High | $-0.26 | $-0.09 | $2.06 | $0.28 | $0.37 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $26M | $27M |
| Low | $26M | $26M |
| High | $27M | $28M |
| EBITDA Avg | $-2M | $-2M |
| Low | $-2M | $-2M |
| High | $-2M | $-2M |
| EBIT Avg | $-2M | $-2M |
| Low | $-2M | $-3M |
| High | $-2M | $-2M |
| Net Income Avg | $-7M | $-7M |
| Low | $-7M | $-7M |
| High | $-6M | $-7M |
| EPS Avg | $-0.07 | $-0.08 |
| Low | $-0.08 | $-0.08 |
| High | $-0.07 | $-0.07 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 |